Sentences with phrase «embryonic stem cell therapy for»

A much - watched clinical trial on embryonic stem cell therapy for spinal cord injuries was dropped by Menlo Park biotech Geron in 2011.

A clinical trial in the Republic of Korea for patients with degenerative eye diseases is the first to test the safety of an embryonic stem cell therapy for people of Asian descent.

Advanced Cell Technology, based in Santa Monica California, is developing embryonic stem cell therapies for macular degeneration and other conditions using cells obtained non-destructively from an early embryo called a blastocyst.

Not exact matches

The truth, of course, is that there are no human embryonic stem - cell therapies even in clinical trial, let alone ready for therapy, and there have been no major treatment....

(In many ways it is worse than when John Edwards said in 2004 that if people voted for John Kerry, people like Christopher Reeve would get out of their wheelchairs and walk from embryonic stem cell therapies.)

In the past year, the South Korean Food and Drug Administration (FDA) has approved the world's first three stem - cell treatments — Hearticellgram - AMI, Cupistem and Cartistem — which followed on the heels of clinical tests for human embryonic stem - cell therapies approved in 2010, according to the health ministry.

The immediate payoff was a commercialization deal in age - related macular degeneration in which Pfizer became the first big pharma company to make a move into the use of embryonic stem cells as the basis for a tissue regeneration therapy.

Finding may enhance understanding of human embryonic stem cells and lead to better models for regenerative therapies

The study, which followed four individuals for a year after they were treated with embryonic stem cell - derived retinal pigment epithelial cells for macular degeneration, observed no serious side effects (tumor growth or other unexpected effects) related to the therapy.

Because the precise activation of Hox genes is essential for a cell's fate, «the research should prove extremely useful in developing novel embryonic stem cell - based therapies, Mazzoni adds.

The world's first chimeric monkeys were created in a laboratory last year, and they offer surprising new insights into embryonic stem cell therapy: One reason for often - poor treatment outcomes may be that we're using embryos that are, strangely, just too old.

A fix for broken rat hearts Scientists this week successfully implanted human embryonic stem cells into rats that suffered heart attacks, coming a heartbeat closer to realizing the full potential of such therapy.

For these cells to be as useful as embryonic stem cells, «we have to find a way to avoid retroviruses before application in cell therapy», Yamanaka says, as they could result in tumours.

In a bid to counteract some of the hype, scientists came to Rockefeller University here last week for a 1 - day conference that offered a clear - eyed look at obstacles that will have to be surmounted before human embryonic stem (ES) cells can be used in therapy.

It is not known how long it will take for embryonic stem cells to become a useful therapy or whether they will ever directly do so.

After hearing a brief explanation that laid out the different sources of stem cells (but left undiscussed their current uses or future potential for therapy), the respondents offered a slightly more nuanced set of views, and only a slight majority (52 %) supported embryonic stem cell research.

Although we agree that greater investments are needed in the clinical development of these therapies, we disagree with the authors» suggestion that, relative to embryonic stem cells, adult stem cells provide a superior vehicle for cell - based therapies because they lack tumorigenic activity, can be prepared by methods approved by the Food and Drug Administration (FDA), and have been free of ethical controversy.

Derivation of pluripotent stem cells, either of embryonic origin or following genetic reprogramming, has opened the path for an alternative source for epidermal cell therapy as these cells are both immortal and pluripotent, theoretically capable of providing any requested number of cells of any desired phenotype.

For the first time, through the use of human embryonic stem cells (hES) sourced from pre-implantation diagnosis, researchers from Inserm's Institute for Stem Cell Therapy and Exploration of Monogenic Diseases (I - Stem) have successfully identified the previously unknown mechanisms involved in Steinert» disease, also known as type 1 myotonic dystropFor the first time, through the use of human embryonic stem cells (hES) sourced from pre-implantation diagnosis, researchers from Inserm's Institute for Stem Cell Therapy and Exploration of Monogenic Diseases (I - Stem) have successfully identified the previously unknown mechanisms involved in Steinert» disease, also known as type 1 myotonic dystrostem cells (hES) sourced from pre-implantation diagnosis, researchers from Inserm's Institute for Stem Cell Therapy and Exploration of Monogenic Diseases (I - Stem) have successfully identified the previously unknown mechanisms involved in Steinert» disease, also known as type 1 myotonic dystropfor Stem Cell Therapy and Exploration of Monogenic Diseases (I - Stem) have successfully identified the previously unknown mechanisms involved in Steinert» disease, also known as type 1 myotonic dystroStem Cell Therapy and Exploration of Monogenic Diseases (I - Stem) have successfully identified the previously unknown mechanisms involved in Steinert» disease, also known as type 1 myotonic dystroStem) have successfully identified the previously unknown mechanisms involved in Steinert» disease, also known as type 1 myotonic dystrophy.

Not so long ago, human embryonic stem cell (hESC) research and SCNT were being hailed as the future of regenerative medicine, capable of generating cures and therapies for any number of diseases and conditions.

This information could then be used to prompt embryonic stem cells to differentiate in the culture dish into neurons for potential use in cell - replacement therapy.

Embryonic cell lines and autologous embryonic stem cells generated through therapeutic cloning have also been proposed as promising candidates for future tEmbryonic cell lines and autologous embryonic stem cells generated through therapeutic cloning have also been proposed as promising candidates for future tembryonic stem cells generated through therapeutic cloning have also been proposed as promising candidates for future therapies.

Such an immunological exemption could alleviate many concerns about using cells for therapy that don't exactly match the recipient's immune system - such as existing embryonic stem cell lines that are not directly derived from the recipient.

This approach to derive patient - specific Embryonic Stem cell - like cells (iPS cells) is going to open up research into the genetic causes of disease and the search for therapies not only for such diseases, but also for repairing tissues damaged in other ways.

In addition, we use our expertise to facilitate the development of functionally mature beta cells from embryonic stem cells for cell replacement therapies of type 1 diabetes.

Virtually identical to human embryonic stem cells (hESCs) except for their origin of isolation, the recently created induced pluripotent stem cells (iPSCs)(Yu et al., 2007; Takahashi et al., 2007) hold much potential for use in regenerative therapies.

For only the second time, the Food and Drug Administration approved a company's request to test an embryonic stem cell - based therapy on human patients.

The US Food and Drug Administration's linkurl: decision; https://www.the-scientist.com/blog/display/55353/ to green light a human embryonic stem cell - based therapy for spinal cord injury isn't just good news for the biotech in question, Geron Corp., analysts say — instead, they argue, the move opens the door to an entire market that has heretofore been stymied.

YDSTIE: So does this move us any closer to the day when embryonic stem cells can actually be used for therapy?

It's no accident, for instance, that both early studies of embryonic stem - cell therapies — those of Geron and Advanced Cell — involved cells of the nervous syscell therapies — those of Geron and Advanced Cell — involved cells of the nervous sysCell — involved cells of the nervous system.

Jaenisch believes they will eventually succeed and points out that the technique could eventually yield a bountiful supply of custom human embryonic stem cells for use in therapy.

Lanza's dream of turning human embryonic stem cells into therapies for the sick and the suffering is taking a huge step closer to reality.

«If we overcome the other obstacles, this approach could one day provide custom human embryonic stem cells for use in therapy.»

Patient - specific stem cells may offer an alternative to embryonic stem cells that will skirt the need for immunosuppressive therapy as well as the social and political ramifications of embryonic stem cell research, but their utility extends far beyond such groundbreaking advances and will assist future clinical practice and patient care.

96/3: 45 RNF12 is essential for X-inactivation in female mouse embryonic stem cells, is required for female mouse development, and might be a target for future therapies to treat X-linked disorders in females: Evidence from a mouse knockout model.

Late last year the preeminent firm in the field, Silicon Valley's Geron, abdicated its leadership position in the midst of the first - ever FDA - approved clinical trial for an embryonic - stem - cell therapy.

Professor Elly Tanaka and her research group at the DFG Research Center for Regenerative Therapies Dresden — Cluster of Excellence at the TU Dresden (CRTD) demonstrated for the first time the in vitro growth of a piece of spinal cord in three dimensions from mouse embryonic stem cells.